RAFAEL HOLDINGS, INC. Interest Income, Other
RAFAEL HOLDINGS, INC. (RFL) reported Interest Income, Other of $286.00 thousand for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. interest income, other for the quarter ending 2026-04-30 was $286.00K, a 39.41% decline year-over-year.
- RAFAEL HOLDINGS, INC. interest income, other for the quarter ending 2026-01-31 was $337.00K, a 31.08% decline year-over-year.
- RAFAEL HOLDINGS, INC. interest income, other for the quarter ending 2025-10-31 was $399.00K, a 29.75% decline year-over-year.
- RAFAEL HOLDINGS, INC. interest income, other for the quarter ending 2025-07-31 was $467.00K, a 22.94% decline year-over-year.
- RAFAEL HOLDINGS, INC. interest income, other for fiscal 2025 was $2.00M, a 16.24% decline from fiscal 2024.
- RAFAEL HOLDINGS, INC. interest income, other for fiscal 2024 was $2.38M, a 26.74% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. interest income, other for fiscal 2023 was $3.25M, a 1518.41% increase from fiscal 2022.
- RAFAEL HOLDINGS, INC. interest income, other for fiscal 2022 was $201.00K, a 9950.00% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month | Interest Income, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2026-04-30 | $286.00K 10-Q · filed 2026-06-11 | $623.00K derived: sum of 2 quarters · filed 2026-06-11 | $1.02M 10-Q · filed 2026-06-11 | $1.49M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2026-01-31 | $337.00K 10-Q · filed 2026-03-16 | $736.00K 10-Q · filed 2026-03-16 | $1.20M derived: sum of 3 quarters · filed 2026-03-16 | $1.68M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-10-31 | $399.00K 10-Q · filed 2025-12-12 | $866.00K derived: sum of 2 quarters · filed 2025-12-12 | $1.34M derived: sum of 3 quarters · filed 2026-06-11 | $1.83M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-07-31 | $467.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $939.00K derived: sum of 2 quarters · filed 2026-06-11 | $1.43M derived: sum of 3 quarters · filed 2026-06-11 | $2.00M 10-K · filed 2025-10-29 | |
| 2025-04-30 | $472.00K 10-Q · filed 2026-06-11 | $961.00K derived: sum of 2 quarters · filed 2026-06-11 | $1.53M 10-Q · filed 2026-06-11 | $2.13M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-01-31 | $489.00K 10-Q · filed 2026-03-16 | $1.06M 10-Q · filed 2026-03-16 | $1.66M derived: sum of 3 quarters · filed 2026-03-16 | $2.17M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-10-31 | $568.00K 10-Q · filed 2025-12-12 | $1.17M derived: sum of 2 quarters · filed 2025-12-12 | $1.68M derived: sum of 3 quarters · filed 2025-12-12 | $2.37M derived: sum of 4 quarters · filed 2025-12-12 | |
| 2024-07-31 | $606.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $1.11M derived: sum of 2 quarters · filed 2025-10-29 | $1.80M derived: sum of 3 quarters · filed 2025-10-29 | $2.38M 10-K · filed 2025-10-29 | |
| 2024-04-30 | $502.00K 10-Q · filed 2025-06-11 | $1.20M derived: sum of 2 quarters · filed 2025-06-11 | $1.78M 10-Q · filed 2025-06-11 | $2.73M derived: sum of 4 quarters · filed 2025-06-11 | |
| 2024-01-31 | $693.00K 10-Q · filed 2025-03-14 | $1.27M 10-Q · filed 2025-03-14 | $2.23M derived: sum of 3 quarters · filed 2025-03-14 | $3.76M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-10-31 | $582.00K 10-Q · filed 2024-12-11 | $1.53M derived: sum of 2 quarters · filed 2024-12-20 | $3.06M derived: sum of 3 quarters · filed 2024-12-20 | $3.63M derived: sum of 4 quarters · filed 2024-12-20 | |
| 2023-07-31 | $952.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $2.48M derived: sum of 2 quarters · filed 2024-12-20 | $3.04M derived: sum of 3 quarters · filed 2024-12-20 | $3.25M 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | $1.53M 10-Q · filed 2024-06-14 | $2.09M derived: sum of 2 quarters · filed 2024-06-14 | $2.30M 10-Q · filed 2024-06-14 | $2.44M derived: sum of 4 quarters · filed 2024-06-14 | |
| 2023-01-31 | $562.00K 10-Q · filed 2024-03-14 | $770.00K 10-Q · filed 2024-03-14 | $913.00K derived: sum of 3 quarters · filed 2024-03-14 | $966.00K derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-10-31 | $208.00K 10-Q · filed 2023-12-14 | $351.00K derived: sum of 2 quarters · filed 2023-12-14 | $404.00K derived: sum of 3 quarters · filed 2023-12-14 | ||
| 2022-07-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $196.00K derived: sum of 2 quarters · filed 2023-10-30 | $201.00K 10-K · filed 2023-10-30 | ||
| 2022-04-30 | $53.00K 10-Q · filed 2023-06-13 | $58.00K 10-Q · filed 2023-06-13 | |||
| 2021-10-31 | $188.00K 10-Q · filed 2022-12-13 | $187.00K derived: sum of 2 quarters · filed 2022-12-13 | $189.00K derived: sum of 3 quarters · filed 2022-12-13 | ||
| 2021-07-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $1.00K derived: sum of 2 quarters · filed 2022-10-31 | $2.00K 10-K · filed 2022-10-31 | ||
| 2021-04-30 | $2.00K 10-Q · filed 2022-06-14 | $3.00K 10-Q · filed 2022-06-14 | |||
| 2019-07-31 | $37.00K 10-K · filed 2020-10-29 | $333.00K 10-K · filed 2019-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |